Bone Drug Fails to Prevent Breast Cancer Recurrence: Study (HealthDay)
HealthDay – SUNDAY, Sept. 25 (HealthDay News) — The bone drug Zometa, once considered a promising weapon to reduce the risk of breast cancer recurrence, should not be used routinely in treatment of the disease, researchers say.
View full post on Yahoo! News: Health News
Leave a Reply